JP5067529B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP5067529B2 JP5067529B2 JP2006335330A JP2006335330A JP5067529B2 JP 5067529 B2 JP5067529 B2 JP 5067529B2 JP 2006335330 A JP2006335330 A JP 2006335330A JP 2006335330 A JP2006335330 A JP 2006335330A JP 5067529 B2 JP5067529 B2 JP 5067529B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mass
- component
- oil
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 57
- 239000000284 extract Substances 0.000 claims description 38
- 210000000214 mouth Anatomy 0.000 claims description 22
- 239000002324 mouth wash Substances 0.000 claims description 21
- 229940051866 mouthwash Drugs 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 18
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 14
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 14
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 claims description 13
- 239000010628 chamomile oil Substances 0.000 claims description 12
- 235000019480 chamomile oil Nutrition 0.000 claims description 12
- 241001071795 Gentiana Species 0.000 claims description 10
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 claims description 10
- 239000010649 ginger oil Substances 0.000 claims description 8
- 239000001722 capsicum frutescens oleoresin Substances 0.000 claims description 7
- 229940050948 capsicum oleoresin Drugs 0.000 claims description 7
- 244000056139 Brassica cretica Species 0.000 claims description 5
- 235000003351 Brassica cretica Nutrition 0.000 claims description 5
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 5
- 235000008496 Drimys aromatica Nutrition 0.000 claims description 5
- 240000002262 Litsea cubeba Species 0.000 claims description 5
- 235000012854 Litsea cubeba Nutrition 0.000 claims description 5
- 235000016720 allyl isothiocyanate Nutrition 0.000 claims description 5
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 5
- 239000010651 grapefruit oil Substances 0.000 claims description 5
- 235000010460 mustard Nutrition 0.000 claims description 5
- VQEONGKQWIFHMN-UHFFFAOYSA-N Nordihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCC(C)C)=CC=C1O VQEONGKQWIFHMN-UHFFFAOYSA-N 0.000 claims description 4
- 229940089116 arnica extract Drugs 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 4
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 claims description 3
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 3
- 229960000401 tranexamic acid Drugs 0.000 claims description 3
- SVIJYLPSHPPVQF-UHFFFAOYSA-N 2-[2,2-diaminoethyl(dodecyl)amino]acetic acid Chemical compound CCCCCCCCCCCCN(CC(N)N)CC(O)=O SVIJYLPSHPPVQF-UHFFFAOYSA-N 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 2
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 claims description 2
- 229920001144 Hydroxy alpha sanshool Polymers 0.000 claims description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
- PSKIOIDCXFHNJA-UHFFFAOYSA-N Sanshool Natural products CC=CC=CC=CCCC=CC=CC(=O)NC(C)C PSKIOIDCXFHNJA-UHFFFAOYSA-N 0.000 claims description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 2
- SBXYHCVXUCYYJT-UEOYEZOQSA-N alpha-Sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)C SBXYHCVXUCYYJT-UEOYEZOQSA-N 0.000 claims description 2
- 229960001948 caffeine Drugs 0.000 claims description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
- 235000017663 capsaicin Nutrition 0.000 claims description 2
- 229960002504 capsaicin Drugs 0.000 claims description 2
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 claims description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229960003500 triclosan Drugs 0.000 claims description 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 claims 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 claims 1
- 238000005259 measurement Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 230000003304 psychophysiological effect Effects 0.000 description 6
- 210000000467 autonomic pathway Anatomy 0.000 description 5
- 239000010634 clove oil Substances 0.000 description 5
- 239000010642 eucalyptus oil Substances 0.000 description 5
- 229940044949 eucalyptus oil Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000009637 wintergreen oil Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241000286209 Phasianidae Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000007177 brain activity Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- -1 sorbit Chemical compound 0.000 description 3
- 241000208983 Arnica Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 210000003403 autonomic nervous system Anatomy 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000005037 parasympathetic nerve Anatomy 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 240000003409 Gentiana lutea Species 0.000 description 1
- 235000002873 Gentiana lutea Nutrition 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、継続して使用しても飽きることがなく、さらに継続して使用する意向が高まる口腔用組成物に関するものである。 The present invention relates to a composition for oral cavity that does not get tired even if it is continuously used, and further increases the intention to use it continuously.
従来、う蝕又は歯周病の原因であるプラークを除去したり、口腔内の清浄化のために歯磨きや洗口剤等の口腔用組成物が用いられ、口腔ケアがなされている。しかしながら、口腔ケアは継続し習慣化してこそ意味があるものの、口腔ケアの継続によって、使用する口腔用組成物に飽きてしまい、口腔ケアの継続が中断してしまうことがある。 Conventionally, oral care such as toothpaste and mouthwash is used to remove plaque that causes caries or periodontal disease and to clean the oral cavity. However, although oral care is meaningful only if it continues and becomes a habit, continuation of oral care may get bored with the oral composition to be used, and the continuation of oral care may be interrupted.
以上のことから、口腔用組成物の使用当初の使用感にかかわらず、一定期間継続して使用しても口腔用組成物に飽きることがなく、さらに継続して使用する意向が高まり、長く使用し続けられるものが望まれていた。なお、本発明に関連する先行技術文献としては下記が挙げられる。 From the above, regardless of the initial use feeling of the oral composition, even if it is used continuously for a certain period of time, it will not get bored with the oral composition, and the intention to use it will continue to increase, and it will be used for a long time There was a need for something that could continue. In addition, the following is mentioned as a prior art document relevant to this invention.
本発明は上記事情に鑑みなされたもので、一定期間継続して使用しても飽きることがなく、さらに継続して使用する意向が高まり、口腔ケアを継続させ習慣化しやすくする口腔用組成物を提供することを目的とする。 The present invention has been made in view of the above circumstances, and does not get tired even if it is used continuously for a certain period of time, and further increases the intention to use it continuously. The purpose is to provide.
本発明者は、上記目的を達成するため鋭意検討した結果、カシア油、カモミール油、ナツメグ油、ジンジャー油、ウインターグリーン油、クローブ油、及びユーカリ油が、脳波と自律神経の双方に何らかの効果を与え、心理生理的効果があることを知見した。さらに、このような(A)心理的効果を与える特定の成分と、(B)刺激を与える特定の成分と、(C)苦味を有する特定の成分とを、それぞれ特定量配合し、香味面から改良することにより、一定期間継続使用しても飽きることがなく、さらに継続して使用する意向が高まること(以下、高継続使用意向と略す場合がある。)を知見し、本発明をなすに至ったものである。 As a result of intensive studies to achieve the above object, the present inventor has found that cassia oil, chamomile oil, nutmeg oil, ginger oil, wintergreen oil, clove oil, and eucalyptus oil have some effect on both the electroencephalogram and the autonomic nerve. And found that there is a psychophysiological effect. Furthermore, the specific component which gives such (A) psychological effect, (B) the specific component which gives irritation | stimulation, and the specific component which has (C) bitterness respectively mix | blends specific amount, and from a flavor side By making improvements, we know that we will not get bored even if it is used continuously for a certain period of time, and that we intend to use it further (hereinafter sometimes abbreviated as “high intention to use continuously”), and make the present invention. It has come.
従って、本発明は下記発明を提供する。
下記1)の(A)〜(C)成分の組み合わせであって、(A)成分を組成物中0.0001〜3質量%と、(B)成分を組成物中0.0005〜1質量%と、(C)成分を組成物中0.001〜3質量%とを含む口腔用組成物。
1)
(A)カシア油、カモミール油及びナツメグ油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン
(C)ゲンチアナ抽出物
Accordingly, the present invention provides the following inventions.
The combination of the components (A) to (C) in the following 1), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
1)
(A) One or more selected from cassia oil, chamomile oil and nutmeg oil (B) capsicum oleoresin (C) gentian extract
本発明の口腔用組成物によれば、一定期間継続使用しても飽きることがなく、さらに継続して使用する意向を高め、口腔ケアを継続させ習慣化しやすくできる。 According to the composition for oral cavity of the present invention, even if it is continuously used for a certain period of time, it does not get tired, and further, the intention to use it continuously can be increased, and oral care can be continued to make it easy to become a habit.
本発明の口腔用組成物は、下記(A)成分0.0001〜3質量%と、(B)成分0.0005〜1質量%と、(C)成分0.001〜3質量%とを含む口腔用組成物である。 The composition for oral cavity of this invention contains 0.0001-3 mass% of the following (A) component, 0.005-1 mass% of (B) component, and 0.001-3 mass% of (C) component. It is a composition for oral cavity.
(A)成分は、カシア油、カモミール油、ナツメグ油、ジンジャー油、ウインターグリーン油、クローブ油、及びユーカリ油から選ばれる1種又は2種以上である。これらの成分は、脳波(快・不快、鎮静・興奮)、及び自律神経(リラックス・活動的・興奮・嫌な感じ)のいずれにも影響を与え、心理生理的影響剤である。その測定方法については、後述の試験例において詳細に説明する。本発明においては、(A)成分の中でも、特にカシア油、カモミール油、ナツメグ油が好ましい。 The component (A) is one or more selected from cassia oil, chamomile oil, nutmeg oil, ginger oil, winter green oil, clove oil, and eucalyptus oil. These components affect any of electroencephalograms (pleasant / unpleasant, sedation / excitement) and autonomic nerves (relaxing / active / exciting / disgusting feeling) and are psychophysiological influencing agents. The measuring method will be described in detail in a test example described later. In the present invention, among the component (A), cassia oil, chamomile oil, and nutmeg oil are particularly preferable.
(A)成分の配合量は、口腔用組成物中0.0001〜3質量%であり、好ましくは0001〜0.3質量%である。(A)成分の配合量が0.0001〜3質量%の範囲外であると、高継続使用意向を示すことができない。 (A) The compounding quantity of a component is 0.0001-3 mass% in an oral cavity composition, Preferably it is 0001-0.3 mass%. When the blending amount of the component (A) is outside the range of 0.0001 to 3% by mass, it is not possible to show a high intention to use continuously.
(B)成分は、カプシカムオレオレジン、カプサイシン、ジヒドロカプサイシン、ノルジヒドロカプサイシン、ピペリン、サンショウオール、マウンテンペッパー、ジアリルジサルファイド、アリルイソチオシアネート、及びマスタードから選ばれる1種又は2種以上であり、主に刺激を与える成分である。本発明においては、(B)成分の中でも、特にカプシカムオレオレジンが好ましい。 Component (B) is one or more selected from capsicum oleoresin, capsaicin, dihydrocapsaicin, nordihydrocapsaicin, piperine, sanshool, mountain pepper, diallyl disulfide, allyl isothiocyanate, and mustard. Yes, it is a component that mainly stimulates. In the present invention, capsicum oleoresin is particularly preferable among the components (B).
(B)成分の配合量は、口腔用組成物中0.0005〜1質量%であり、好ましくは0.001〜0.5質量%である。(B)成分の配合量が0.0005〜1質量%の範囲外であると、高継続使用意向を示すことができない。 (B) The compounding quantity of a component is 0.0005-1 mass% in an oral composition, Preferably it is 0.001-0.5 mass%. When the blending amount of the component (B) is out of the range of 0.0005 to 1% by mass, it is not possible to show a high intention to continue use.
(C)キジツ抽出物、クララ抽出物、チンピ抽出物、ホップ抽出物、ジュウヤク抽出物、アルニカ抽出物、リョクチャ抽出物、ゲンチアナ抽出物、グレープフルーツ油、トラネキサム酸、塩化セチルピリジニウム、塩酸クロルヘキシジン、グルコン酸クロルヘキシジン、トリクロサン、イソプロピルメチルフェノール、カフェイン、フェノキシエタノール、及びドデシルジアミノエチルグリシンから選ばれる1種又は2種以上であり、主に苦味を有する成分である。本発明においては、(C)キジツ抽出物、クララ抽出物、チンピ抽出物、ホップ抽出物、ジュウヤク抽出物、アルニカ抽出物、リョクチャ抽出物、ゲンチアナ抽出物及びグレープフルーツ油から選ばれる1種又は2種以上を用いるものであり、特にゲンチアナ抽出物が好ましい。 (C) Pheasant extract, Clara extract, Chinpi extract, Hop extract, Jujuy extract, Arnica extract, Ryokucha extract, Gentian extract, Grapefruit oil, tranexamic acid, cetylpyridinium chloride, chlorhexidine hydrochloride, gluconic acid It is one or more selected from chlorhexidine, triclosan, isopropylmethylphenol, caffeine, phenoxyethanol, and dodecyldiaminoethylglycine, and is a component mainly having a bitter taste. In the present invention, (C) one or two selected from a pheasant extract, a clara extract, a chimpan extract, a hop extract, a juicy extract, an arnica extract, a ryokcha extract, a gentian extract and a grapefruit oil The gentian extract is particularly preferable.
(C)成分の中でも、キジツ抽出物、クララ抽出物、チンピ抽出物、ホップ抽出物、ジュウヤク抽出物、アルニカ抽出物、リョクチャ抽出物、及びゲンチアナ抽出物は、市販品あるいは公知の抽出方法よって得られたものを使用することができる。 Among the components (C), a pheasant extract, a clara extract, a chimpan extract, a hop extract, a juicy extract, an arnica extract, a ryokcha extract, and a gentian extract can be obtained by a commercially available product or a known extraction method. Can be used.
キジツ(枳実)はカン科のダイダイ、ナツダイダイ、その他同属植物の未熟果実からなる生薬である。クララ(学名:Sophora flavescens Ait)は、マメ科の多年草である。チンピ(陳皮)はミカン科のウンシュウミカンの成熟した果皮からなる生薬である。ホップはビールの原料として有名であり、アサ科の植物である。ジュウヤク(十薬)は、ドクダミ科(Sauruaceae)のドクダミ(Houttuynia cordata Thunberg)の花期の地上部からなる生薬である。アルニカは、キク科の植物アルニカの頭花から抽出されるハーブの1種である。リョクチャ(緑茶)は、茶葉を蒸して水分蒸発させ、もんで乾燥させて作る不発酵茶のことである。ゲンチアナ(学名Gentiana lutea L.)はリンドウ科に属し、根と根茎を多少発酵させて乾燥して用いる生薬である。 Pheasant is a herbal medicine consisting of immature fruits of candied daidai, natsudaidai and other related plants. Clara (scientific name: Sophora flavescens Ait) is a perennial of the legume family. Chimpi is a herbal medicine made of mature pericarp of Citrus unshiu. Hop is famous as a raw material for beer and is a plant of the family Asapaceae. Zyuyaku (ten drugs) is a herbal medicine consisting of the above-ground part of the flowering stage of Houttuynia cordata Thunberg of the Sauraceae family. Arnica is a kind of herb extracted from the flower of Arnica plant Arnica. Ryokucha (green tea) is a non-fermented tea made by steaming tea leaves to evaporate moisture and drying them. Gentiana (scientific name Gentiana lutea L.) belongs to the Gentianaceae family, and is a herbal medicine that is used after some fermentation of the roots and rhizomes and drying.
上記抽出方法に用いる溶媒としては、水;メタノール、エタノール、プロパノール、ブタノール等のアルコール類;プロピレングリコール、ブチレングリコール等の多価アルコール類等が挙げられ、これらを単独で又は2種以上の混合溶媒として用いることができる。 Examples of the solvent used in the extraction method include water; alcohols such as methanol, ethanol, propanol, and butanol; polyhydric alcohols such as propylene glycol and butylene glycol, and the like. These may be used alone or in combination of two or more. Can be used as
上記抽出方法における各種条件は、特に制限されるものではないが、通常、抽出原料と上記抽出溶媒との比率は、質量比で抽出原料:抽出溶媒=1:2〜1:50程度の範囲が好ましい。また、抽出温度は、5〜80℃の範囲が好ましく、1時間〜1週間、抽出溶媒に浸漬したり、攪拌したりすることによって行うことが好ましい。なお、抽出pHは、極端な酸性又はアルカリ性でなければ、特に制限はない。 Various conditions in the extraction method are not particularly limited, but the ratio of the extraction raw material to the extraction solvent is usually in a range of about 1: 2 to 1:50 extraction raw material: extraction solvent = 1: 50 by mass ratio. preferable. The extraction temperature is preferably in the range of 5 to 80 ° C., and is preferably performed by immersing or stirring in the extraction solvent for 1 hour to 1 week. The extraction pH is not particularly limited as long as it is not extremely acidic or alkaline.
上記抽出溶媒が、水、エタノール、水/エタノール(含水エタノール)等の非毒性の溶媒である場合は、抽出物をそのまま用いても良く、あるいは希釈液として用いてもよい。また、上記抽出物を濃縮エキスとしてもよく、凍結乾燥等により乾燥粉末物にしたり、ペースト状に調製したりしてもよい。なお、他の溶媒を用いた場合は、溶媒を留去後、乾燥分を非毒性の溶媒で希釈して用いることが好ましい。 When the extraction solvent is a non-toxic solvent such as water, ethanol, water / ethanol (hydrous ethanol), the extract may be used as it is or as a diluent. Moreover, the said extract may be used as a concentrated extract, and may be made into a dry powder by freeze drying or the like, or may be prepared in a paste form. When other solvents are used, it is preferable to distill the solvent and dilute the dried portion with a non-toxic solvent.
(C)成分の配合量は、口腔用組成物中0.001〜3質量%であり、好ましくは0.01〜1.5質量%である。(B)成分の配合量が0.001〜3質量%の範囲外であると、高継続使用意向を示すことができない。 (C) The compounding quantity of a component is 0.001-3 mass% in an oral cavity composition, Preferably it is 0.01-1.5 mass%. When the blending amount of the component (B) is outside the range of 0.001 to 3% by mass, it is not possible to indicate a high continuous use intention.
本発明の口腔用組成物には、上記(A)〜(C)成分の他に、口腔用組成物に使用可能な任意成分を添加することができる。具体的に保湿剤として、グリセリン、ソルビット、プロピレングリコール、ポリエチレングリコール等の多価アルコール、界面活性剤としてラウリル硫酸ナトリウム等のアニオン界面活性剤、ラウリン酸デカグリセリル、ポリオキシエチレン硬化ヒマシ油、ミリスチン酸ジエタノールアミド等の非イオン界面活性剤、有効成分としてフッ化ナトリウム等のフッ化物、デキストラナーゼ、ムタナーゼ等の酵素、トラネキサム酸、ε−アミノカプロン酸等、香味剤としてはサッカリンナトリウム、メントール、ペパーミント、スペアミント等が挙げられる。なお、これら任意成分の配合量は、本発明の効果を妨げない範囲で有効量とすることができる。 In addition to the components (A) to (C), an optional component that can be used for the oral composition can be added to the oral composition of the present invention. Specific examples of moisturizing agents include polyhydric alcohols such as glycerin, sorbit, propylene glycol, and polyethylene glycol, surfactants such as anionic surfactants such as sodium lauryl sulfate, decaglyceryl laurate, polyoxyethylene hydrogenated castor oil, and myristic acid. Nonionic surfactants such as diethanolamide, fluorides such as sodium fluoride as active ingredients, enzymes such as dextranase and mutanase, tranexamic acid, ε-aminocaproic acid, etc., saccharin sodium, menthol, peppermint, spearmint as flavoring agents Etc. In addition, the compounding quantity of these arbitrary components can be made into an effective quantity in the range which does not prevent the effect of this invention.
本発明の口腔用組成物は、上記必須成分、任意成分、及び水(口腔用組成物が100質量%となるように残部配合)を混合し、常法によって得ることができる。 The oral composition of the present invention can be obtained by a conventional method by mixing the above-mentioned essential components, optional components, and water (the remainder blended so that the oral composition is 100% by mass).
本発明の口腔用組成物は、歯磨き、洗口剤として用いることができ、洗口剤として好適である。その剤型としては、液体、軟膏、ペースト、ゲル、ゾル、クリーム等に調製することができるが、液体が好ましい。 The composition for oral cavity of this invention can be used as a toothpaste and a mouthwash, and is suitable as a mouthwash. The dosage form can be prepared as a liquid, ointment, paste, gel, sol, cream, etc., but liquid is preferred.
本発明の口腔用組成物は、一定期間(14日以上程度)継続使用しても飽きることがなく、さらに継続して使用する意向を高め、口腔ケアを継続させ習慣化しやすくすることができる。 The composition for oral cavity of the present invention does not get tired even if it is continuously used for a certain period (about 14 days or more), further increases the intention to use it continuously, makes it possible to continue oral care and make it easy to become a habit.
以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記の実施例に制限されるものではない。なお、下記の例において特に明記のない場合は、組成の「%」は質量%を示す。 EXAMPLES Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not restrict | limited to the following Example. In the following examples, unless otherwise specified, “%” in the composition represents mass%.
[試験例]
カモミール油、カシア油、ユーカリ油、ウインターグリーン油、ナツメグ油、クローブ油、ジンジャー油、タイムホワイト油、及びシソ油について、下記方法で洗口剤を調製し、この洗口剤を用い被験者8人で、下記方法に基づいて心理生理的効果を評価した。結果を表4に示す。
[Test example]
For chamomile oil, cassia oil, eucalyptus oil, winter green oil, nutmeg oil, clove oil, ginger oil, thyme white oil, and perilla oil, a mouthwash was prepared by the following method, and 8 subjects used this mouthwash. The psychophysiological effects were evaluated based on the following method. The results are shown in Table 4.
洗口剤の調製
カモミール油、カシア油、ウインターグリーン油、ユーカリ油、ナツメグ油、クローブ油、ジンジャー油、タイムホワイト油、及びシソ油をそれぞれ単独で0.1部、以下の洗口剤基剤99.9部に添加し、撹拌溶解させ洗口剤を得た。
洗口剤基剤 組成(%)
クエン酸 0.03
クエン酸ソーダ 0.25
安息香酸ソーダ 0.30
ソルビトール 0.70
グリセリン 1.00
プロピレングリコール 0.50
メチルパラベン 0.10
HCO60 1.00
(ポリオキシエチレン硬化ヒマシ油)
精製水 96.02
合計 99.9
Preparation of mouthwash Chamomile oil, cassia oil, winter green oil, eucalyptus oil, nutmeg oil, clove oil, ginger oil, thyme white oil and perilla oil alone, 0.1 parts each, the following mouthwash base It was added to 99.9 parts and dissolved by stirring to obtain a mouthwash.
Mouthwash base composition (%)
Citric acid 0.03
Sodium citrate 0.25
Sodium benzoate 0.30
Sorbitol 0.70
Glycerin 1.00
Propylene glycol 0.50
Methylparaben 0.10
HCO 60 1.00
(Polyoxyethylene hydrogenated castor oil)
Purified water 96.02
Total 99.9
(1)脳波計測
102.4秒間の脳波計測を連続して5回行った。2回目の計測時間中に開眼して、洗口剤20mLを20秒間口に含み、吐き出した。この洗口剤使用時以外は安静閉眼状態とした。洗口剤を使用する前の第1回計測を洗口剤使用前、第2回計測を洗口剤使用中、第3〜5回計測を洗口剤使用後とした。
)。
(1) Brain wave measurement The brain wave measurement for 102.4 seconds was performed 5 times continuously. During the second measurement time, the eyes were opened, and 20 mL of mouthwash was contained in the mouth for 20 seconds, and then discharged. Except when this mouthwash was used, the eyes were rested and closed. The first measurement before using the mouthwash was made before using the mouthwash, the second measurement was made while using the mouthwash, and the third to fifth measurements were made after using the mouthwash.
).
簡易型α波周波数リズム測定機(ひとセンシング(株)製)を用いて、被験者の脳波を計測した。計測は電極を国際10−20法に従いFp1とFp2の前頭部2部位に装着し、右耳朶をアース、左耳朶を基準電極として前頭部脳波(8〜13Hz)を記録した。記録された脳波の左右それぞれの周波数と時間的変動(ゆらぎ)の解析を行い、吉田教授の理論(参考文献:吉田倫幸、「香りの心理生理作用と有用性の評価」AROMA RESEARCH No.1,38−43(2001))に基づき、生理状態と心理状態を確認した。すなわち左右の脳波の周波数から脳活動度(周波数増加→覚醒状態への推移、周波数減少→睡眠状態への推移)という生理状態を求め、左右の脳波のゆらぎからそれぞれ左リズム度;快−不快、右リズム度;鎮静−興奮という心理学的な2軸における気分の程度と総合的な心理状態を求めた。
評価は洗口剤使用前をブランクとし、使用前に対する「使用中から使用後」の脳活動度と心理状態の変化から効果を判断した。
The subject's brain waves were measured using a simple α-wave frequency rhythm measuring machine (manufactured by Human Sensing Co., Ltd.). For measurement, electrodes were attached to two frontal regions of Fp1 and Fp2 according to the International 10-20 method, and frontal brain waves (8 to 13 Hz) were recorded using the right earlobe as the ground and the left earlobe as the reference electrode. The left and right frequencies and temporal variations (fluctuations) of the recorded brain waves were analyzed, and Professor Yoshida's theory (reference: Yoshiyuki Yoshida, “Evaluation of psychophysiological effects and usefulness of fragrances”, AROMA RESEARCH No. 1, 38-43 (2001)), the physiological state and the psychological state were confirmed. That is, the physiological state of brain activity (frequency increase → transition to arousal state, frequency decrease → transition to sleep state) is obtained from the frequency of the left and right brain waves, and the left rhythm degree from the fluctuations of the left and right brain waves; The degree of right rhythm; sedation-excited psychological degree in two axes and the overall psychological state.
The evaluation was performed using a blank before using the mouthwash, and the effect was judged from changes in brain activity and psychological state "from use to use" compared to before use.
脳活動度については、
[使用中から使用後の活動度の平均値−使用前の活動度]>0となった被験者の数を指標とし、以下の判定基準に基づいて評価した。
About brain activity,
[Average value of activity after use-activity before use-activity before use]> The number of subjects who became 0 was used as an index and evaluated based on the following criteria.
心理状態については、下記の左右リズム度から総合的に判断した。
(2)心電図測定
3分間の装置アイドリングの後、上記(1)脳波計測5回分の時間に合わせ、連続で6分50秒間行った。洗口剤使用前、使用中、及び使用後のタイミングは脳波計測に準拠し、測定後にそれぞれの区間のデータを独立して解析した。
(2) Electrocardiogram measurement After apparatus idling for 3 minutes, the measurement was continuously performed for 6 minutes and 50 seconds in accordance with the time for the above (1) brain wave measurement. The timing before, during and after use of the mouthwash was based on electroencephalogram measurement, and the data of each section were analyzed independently after the measurement.
循環動態波形・ゆらぎ解析ソフトウェア フラクレットWT(大日本製薬(株)製)を用いて、被験者の心電図を測定した。測定は心臓を対角線で挟むように右胸上部にマイナス電極、左胸下部にプラス電極を装着し、また左胸上部にアース電極を装着して行った。心電図のシグナルの波形を基に心拍のゆらぎを解析し、自律神経(交感神経と副交感神経)の活動度を求めた。
評価は洗口剤使用前をブランクとし、使用前に対する「使用中から使用後」の自律神経活動度の変化から効果を判断した。
The electrocardiogram of the subject was measured using a circulatory dynamic waveform / fluctuation analysis software Fraclet WT (Dainippon Pharmaceutical Co., Ltd.). The measurement was performed with a negative electrode on the upper right chest, a positive electrode on the lower left chest, and a ground electrode on the upper left chest so that the heart is sandwiched diagonally. Heart rate fluctuations were analyzed based on the ECG signal waveform to determine the activity of autonomic nerves (sympathetic and parasympathetic).
In the evaluation, the mouthwash before use was blank, and the effect was judged from the change in autonomic nerve activity from “in use to after use” with respect to before use.
すなわち交感神経又は副交感神経の活動度の[使用中から使用後の平均値)−(使用前の平均値]>0となった被験者の数を指標とし、以下の判定基準に基づいて評価した。また、自律神経系のバランスを交感神経及び副交感神経の活動度から判断し、自律神経系解析結果(バランス)として併記した。 That is, evaluation was performed based on the following criteria, using as an index the number of subjects whose [symmetry nerve or parasympathetic nerve activity [average value after use to after use] − (average value before use]> 0). In addition, the balance of the autonomic nervous system was judged from the activity of the sympathetic nerve and the parasympathetic nerve, and was also written as the autonomic nervous system analysis result (balance).
カモミール油、カシア油、ユーカリ油、ウインターグリーン油、ナツメグ油、クローブ油、及びジンジャー油については、脳波及び自律神経の双方に影響を与え、心理生理的影響力を有するものであった。 Chamomile oil, cassia oil, eucalyptus oil, winter green oil, nutmeg oil, clove oil, and ginger oil affected both the electroencephalogram and autonomic nerve, and had psychophysiological influence.
[実施例1〜18、参考例1〜8、比較例1〜17]
表5〜12に示す組成の洗口剤を調製し、下記方法で使用意向を評価した。結果を表中に併記する。
[Examples 1 to 18, Reference Examples 1 to 8, Comparative Examples 1 to 17]
Mouthwashes having the compositions shown in Tables 5 to 12 were prepared, and the intention to use was evaluated by the following methods. The results are also shown in the table.
<使用意向評価方法>
洗口剤を被験者33名にそれぞれ1日2回、1回に10mLずつ2週間連続使用させ、その初回使用時及び2週間後(終了時)の2回、継続して使用したいか否かを下記判定基準で評価した。結果を33名の平均値で示す。
使用意向の判定基準
7;非常に使いたい
6;かなり使いたい
5;やや使いたい
4;どちらでもない
3;やや使いたくない
2;かなり使いたくない
1;非常に使いたくない
<Intended use evaluation method>
Whether or not you want to continue using mouthwashes for 33 subjects each time, twice a day, 10 mL each time for 2 weeks, 2 times after the first use and 2 weeks later (when finished) The following criteria were used for evaluation. A result is shown by the average value of 33 persons.
Judgment Criteria for Use Intention 7; Very Wanted 6; Pretty Wanted 5; Somewhat Wanted 5; Somewhat Wanted 4; Neither Wanted 3; Somewhat Not Wanted 2; Somewhat Not Wanted 1;
下記の式から各々の試料の連続使用による使用意向変化率(%)を求めた。
連続使用による使用意向変化率(%)
=[(2週間連続使用後の使用意向の平均値)−(初回の使用意向の平均値)]/
(初回の使用意向の平均値)×100
From the following formula, the change in intention to use (%) by continuous use of each sample was determined.
Rate of change in intention to use due to continuous use (%)
= [(Average value of intention to use after 2 weeks of continuous use)-(Average value of intention to use for the first time)] /
(Average value of initial intention to use) x 100
上記結果によれば、本発明の口腔用組成物は2週間連続使用後の「使用意向」が高く、使用意向変化率が正の方向に高く、連続使用により嗜好性が上昇した。 According to the above results, the composition for oral cavity of the present invention had a high “intention to use” after continuous use for 2 weeks, a high change in the intent to use, and the preference increased with continuous use.
Claims (11)
1)
(A)カシア油、カモミール油及びナツメグ油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン
(C)ゲンチアナ抽出物 The combination of the components (A) to (C) in the following 1), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
1)
(A) One or more selected from cassia oil, chamomile oil and nutmeg oil (B) capsicum oleoresin (C) gentian extract
2)
(A)カシア油、ナツメグ油及びジンジャー油から選ばれる1種又は2種以上
(B)アリルイソチオシアネート
(C)ジュウヤク抽出物から選ばれる1種又は2種以上とを含む口腔用組成物。 The combination of the components (A) to (C) in the following 2), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
2)
(A) 1 type, or 2 or more types chosen from cassia oil, nutmeg oil, and ginger oil (B) allyl isothiocyanate (C) 1 type, or 2 or more types chosen from a jujube extract.
3)
(A)カシア油及びカモミール油から選ばれる1種又は2種以上
(B)ジヒドロカプサイシン及びマスタードから選ばれる1種又は2種以上
(C)リョクチャ抽出物
4)
(A)カシア油及びカモミール油から選ばれる1種又は2種以上
(B)アリルイソチオシアネート及びマスタードから選ばれる1種又は2種以上
(C)ゲンチアナ抽出物
5)
(A)カシア油及びカモミール油から選ばれる1種又は2種以上
(B)ノルジヒドロカプサイシン、マウンテンペッパー及びサンショウオールから選ばれる1種又は2種以上
(C)チンピ抽出物 The combination of the components (A) to (C) selected from the following 3) to 5), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.00 in the composition. The composition for oral cavity containing 0005-1 mass% and 0.001-3 mass% in (C) component in a composition.
3)
(A) One or more selected from cassia oil and chamomile oil (B) One or more selected from dihydrocapsaicin and mustard (C) Ryokucha extract 4)
(A) One or more selected from cassia oil and chamomile oil (B) One or more selected from allyl isothiocyanate and mustard (C) Gentian extract 5)
(A) One or more kinds selected from cassia oil and chamomile oil (B) One or more kinds selected from nordihydrocapsaicin, mountain pepper and sanshool (C) Chinpi extract
6)
(A)ナツメグ油及びジンジャー油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン及びジヒドロカプサイシンから選ばれる1種又は2種以上
(C)ジュウヤク抽出物及びアルニカ抽出物から選ばれる1種又は2種以上 The combination of the components (A) to (C) in the following 6), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
6)
(A) One or more selected from nutmeg oil and ginger oil (B) One or more selected from capsicum oleoresin and dihydrocapsaicin (C) Selected from juyaku extract and arnica extract 1 type or 2 types or more
7)
(A)カシア油
(B)カプサイシン、マウンテンペッパー及びマスタードから選ばれる1種又は2種以上(C)クララ抽出物、チンピ抽出物及びゲンチアナ抽出物から選ばれる1種又は2種以上 The combination of the components (A) to (C) of the following 7), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
7)
(A) Cassia oil (B) One or more selected from capsaicin, mountain pepper and mustard (C) One or more selected from Clara extract, Chinpi extract and Gentian extract
8)
(A)ナツメグ油
(B)アリルイソチオシアネート
(C)グレープフルーツ油
9)
(A)ナツメグ油
(B)カプシカムオレオレジン及びマスタードから選ばれる1種又は2種以上
(C)クララ抽出物及びグレープフルーツ油から選ばれる1種又は2種以上 The combination of the components (A) to (C) of the following 8) or 9), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 0.0005 in the composition. The composition for oral cavity containing 1 mass% and 0.001-3 mass% in (C) component in a composition.
8)
(A) Nutmeg oil (B) Allyl isothiocyanate (C) Grapefruit oil 9)
(A) Nutmeg oil (B) One or more selected from capsicum oleoresin and mustard (C) One or more selected from Clara extract and grapefruit oil
10)
(A)カモミール油
(B)マウンテンペッパー
(C)クララ抽出物 The combination of the components (A) to (C) of 10) below, wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
10)
(A) Chamomile oil (B) Mountain pepper (C) Clara extract
11)
(A)ジンジャー油
(B)マウンテンペッパー及びアリルイソチオシアネート
(C)グレープフルーツ油 11) The combination of the components (A) to (C) below, wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
11)
(A) Ginger oil (B) Mountain pepper and allyl isothiocyanate (C) Grapefruit oil
12)
(A)カシア油及びナツメグ油から選ばれる1種又は2種以上
(B)カプシカムオレオレジン
(C)ゲンチアナ抽出物 The combination of the components (A) to (C) in the following 12), wherein the component (A) is 0.0001 to 3% by mass in the composition, and the component (B) is 0.0005 to 1% by mass in the composition. And (C) component for oral cavity containing 0.001-3 mass% in a composition.
12)
(A) One or more selected from cassia oil and nutmeg oil (B) Capsicum oleoresin (C) Gentian extract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006335330A JP5067529B2 (en) | 2006-12-13 | 2006-12-13 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006335330A JP5067529B2 (en) | 2006-12-13 | 2006-12-13 | Oral composition |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008143870A JP2008143870A (en) | 2008-06-26 |
JP2008143870A5 JP2008143870A5 (en) | 2011-05-26 |
JP5067529B2 true JP5067529B2 (en) | 2012-11-07 |
Family
ID=39604442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006335330A Active JP5067529B2 (en) | 2006-12-13 | 2006-12-13 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5067529B2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962057B2 (en) * | 2009-04-29 | 2015-02-24 | The Procter & Gamble Company | Methods for improving taste and oral care compositions with improved taste |
MY152711A (en) * | 2009-12-04 | 2014-11-28 | Colgate Palmolive Co | Oral compositions containing a combination of natural extracts and related methods |
MY150829A (en) * | 2009-12-04 | 2014-02-28 | Colgate Palmolive Co | Oral compositions containing extracts of myristica fragrans and related methods |
US20120244086A1 (en) * | 2009-12-04 | 2012-09-27 | Colgate-Palmolive Company | Oral compositions containing extracts of zingiber officinale and related methods |
JP5897843B2 (en) * | 2011-08-11 | 2016-03-30 | 株式会社ロッテ | Composition for oral cavity containing spice extract |
JP5748626B2 (en) * | 2011-09-21 | 2015-07-15 | サンスター株式会社 | Oral composition |
JP6249588B2 (en) * | 2011-09-30 | 2017-12-20 | 小林製薬株式会社 | Oral composition |
JP6111981B2 (en) * | 2013-10-30 | 2017-04-12 | ライオン株式会社 | Liquid oral composition |
CN108969413A (en) * | 2017-06-05 | 2018-12-11 | 狮王株式会社 | Composition for oral cavity |
JP7031253B2 (en) * | 2017-11-29 | 2022-03-08 | ライオン株式会社 | Toothpaste composition |
JP2019112329A (en) | 2017-12-22 | 2019-07-11 | ライオン株式会社 | Oral cavity composition and discoloration suppression method thereof |
WO2021062607A1 (en) * | 2019-09-30 | 2021-04-08 | The Procter & Gamble Company | Oral care compositions comprising hops beta acid and amino acid |
CN114449996B (en) | 2019-09-30 | 2024-10-01 | 宝洁公司 | Oral care compositions comprising hops beta acids and metal ions |
GB2590973B (en) * | 2020-01-10 | 2022-01-12 | Diet Shield Ltd | Composition comprising a lip interacting component |
BR112022016384A2 (en) | 2020-02-18 | 2022-10-11 | Sunstar Americas Inc | ORAL CARE COMPOSITION |
WO2024096835A1 (en) * | 2022-11-01 | 2024-05-10 | Istanbul Medipol Universitesi | Oral care preparations comprising a combination of standardized essential oils and antiseptic agents |
CN116327675B (en) * | 2023-05-19 | 2024-09-24 | 山东大学 | Herbal mouthwash containing lactobacillus sanfranciscensis and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2098476B (en) * | 1981-05-13 | 1984-10-31 | Colgate Palmolive Co | Flavoured aqueous oral composition |
JPS61155315A (en) * | 1984-12-28 | 1986-07-15 | Lion Corp | Composition for oral purpose |
JPH09104891A (en) * | 1995-10-09 | 1997-04-22 | Lion Corp | Perfumery composition |
JP3613631B2 (en) * | 1999-03-31 | 2005-01-26 | サンスター株式会社 | Oral liquid composition |
JP2004018431A (en) * | 2002-06-14 | 2004-01-22 | Kiyomitsu Kawasaki | Perfume composition for oral cavity and oral cavity composition containing the same |
CN101010091A (en) * | 2004-09-02 | 2007-08-01 | 宝洁公司 | Oral care composition comprising essential oils |
JP4883895B2 (en) * | 2004-09-30 | 2012-02-22 | 小川香料株式会社 | Flavoring composition |
EP1874132A1 (en) * | 2005-04-15 | 2008-01-09 | Firmenich Sa | Hot flavour and skin sensation composition |
-
2006
- 2006-12-13 JP JP2006335330A patent/JP5067529B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008143870A (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5067529B2 (en) | Oral composition | |
KR101448283B1 (en) | A Composition of a Bubble Dentifrice and the Method of Making it | |
KR101955468B1 (en) | Preparing method for toothpaste composition comprising natural extracts | |
JP2004083443A (en) | Composition using mastic for preventing and treating periodontal disease and method for preventing and treating periodontal disease | |
EP2716303A1 (en) | Psychic energizer agent and psychic energizer composition | |
JP2011126818A (en) | Dentifrice composition | |
JP2003081800A (en) | Anti-periodontitis agent | |
JP2004520304A (en) | Oral composition for suppressing bad breath | |
JP2681081B2 (en) | Mouthwash composition for hyperesthesia | |
JPH11255636A (en) | Blood circulation promoter | |
JPH0853327A (en) | Hair tonic composed of allantoin or its derivative | |
KR102597516B1 (en) | Fragrance composition for stress relief and psychological stability enhancement containing novel organic compounds as active ingredients | |
JPH0525849B2 (en) | ||
JP3534959B2 (en) | Hair restoration cosmetics | |
KR101321045B1 (en) | Composition of preventing hair loss and promoting hair growth | |
KR102816654B1 (en) | Composition for scalp cleansing and method for producing the same | |
JPH08291018A (en) | Humectant for cosmetic | |
JP7567791B2 (en) | Composition for oral cavity and agent for providing massage sensation to gums | |
JP2005162633A (en) | Salivation promoter, and oral cavity composition and food composition containing the same | |
KR101287800B1 (en) | Oral composition | |
JP7403736B2 (en) | Oral composition | |
JP7508243B2 (en) | Oral Composition | |
JP7672414B2 (en) | Liquid oral composition | |
DE68914451T2 (en) | ORAL SUPPLIES. | |
JP2024093493A (en) | Dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091201 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110412 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110928 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111019 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111216 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120718 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120731 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150824 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5067529 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |